Knee+ technology combines computer vision and deep learning algorithms and works with off-the-shelf AR glasses to track instruments and implants.
Safe Orthopaedics will acquire its contract manufacturing partner to meet growing demand for its implant and instrument kits for spinal surgeries.
The company grew in the low double digits in 1Q20 but was on pace for record procedure volumes before COVID-19 impacted the U.S. orthopedic market in mid-March.
Funds will support commercial launch and postmarket clinical studies of Tapestry to treat Achilles tendon and ligament injuries.
The AMS implant portfolio includes proprietary surface and structural technologies to enhance biomechanical properties of materials for spine procedures.
The agreement extends Smith+Nephew's Positive Connections program to offer customers educational, advisory and financial services.
While Stryker anticipates significant disruption to orthopedic sales in 2Q20, the company is confident the revenue-generating ability of orthopedics will drive the recovery of deferred procedures.
This is the next step of Conventus' transformation as it expands distribution channels and builds its portfolio with product development and acquisitions.
The company declined 12.5% in 1Q20 and believes the market low point will be in the second quarter. ConMed's orthopedic sales for April are projected to decline by 65%.
This investment supports growth of the Photodynamic Bone Stabilization System for minimally invasive intramedullary fixation of bone fractures.